U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ULOCUPLUMAB
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
ulocuplumab [INN]
Preferred Name English
HUMAN ANTI-CXCR4 IGG4 MONOCLONAL ANTIBODY
Common Name English
ULOCUPLUMAB [USAN]
Common Name English
Ulocuplumab [WHO-DD]
Common Name English
BMS-936564
Code English
MDX-1338
Code English
Classification Tree Code System Code
EU-Orphan Drug EU/3/15/1445
Created by admin on Mon Mar 31 23:29:57 GMT 2025 , Edited by admin on Mon Mar 31 23:29:57 GMT 2025
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 23:29:57 GMT 2025 , Edited by admin on Mon Mar 31 23:29:57 GMT 2025
FDA ORPHAN DRUG 457414
Created by admin on Mon Mar 31 23:29:57 GMT 2025 , Edited by admin on Mon Mar 31 23:29:57 GMT 2025
Code System Code Type Description
USAN
AB-44
Created by admin on Mon Mar 31 23:29:57 GMT 2025 , Edited by admin on Mon Mar 31 23:29:57 GMT 2025
PRIMARY
NCI_THESAURUS
C95755
Created by admin on Mon Mar 31 23:29:57 GMT 2025 , Edited by admin on Mon Mar 31 23:29:57 GMT 2025
PRIMARY
EVMPD
SUB178046
Created by admin on Mon Mar 31 23:29:57 GMT 2025 , Edited by admin on Mon Mar 31 23:29:57 GMT 2025
PRIMARY
INN
9854
Created by admin on Mon Mar 31 23:29:57 GMT 2025 , Edited by admin on Mon Mar 31 23:29:57 GMT 2025
PRIMARY
CAS
1375830-34-4
Created by admin on Mon Mar 31 23:29:57 GMT 2025 , Edited by admin on Mon Mar 31 23:29:57 GMT 2025
PRIMARY
DRUG BANK
DB12018
Created by admin on Mon Mar 31 23:29:57 GMT 2025 , Edited by admin on Mon Mar 31 23:29:57 GMT 2025
PRIMARY
FDA UNII
7KNP87L4X4
Created by admin on Mon Mar 31 23:29:57 GMT 2025 , Edited by admin on Mon Mar 31 23:29:57 GMT 2025
PRIMARY
WIKIPEDIA
Ulocuplumab
Created by admin on Mon Mar 31 23:29:57 GMT 2025 , Edited by admin on Mon Mar 31 23:29:57 GMT 2025
PRIMARY
ChEMBL
CHEMBL3039543
Created by admin on Mon Mar 31 23:29:57 GMT 2025 , Edited by admin on Mon Mar 31 23:29:57 GMT 2025
PRIMARY
SMS_ID
100000163642
Created by admin on Mon Mar 31 23:29:57 GMT 2025 , Edited by admin on Mon Mar 31 23:29:57 GMT 2025
PRIMARY
ACTIVE MOIETY
ULOCUPLUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966